The World Health Organization raised the public-health risk level for the Ebola outbreak in the Democratic Republic of Congo to "very high" on Friday [1].
This escalation reflects a critical gap in medical countermeasures, as the specific strain causing the current surge has no proven vaccine and a high fatality rate.
Director-General Dr. Tedros Adhanom Ghebreyesus said the risk in the wider African region is "high," while the global risk remains "low" [1]. The outbreak is centered primarily in Ituri Province in the eastern part of the country [2].
Health officials said the disease is spreading faster than initially expected. There are now approximately 750 suspected cases and 177 suspected deaths [3]. At least 131 deaths have been confirmed [4].
The outbreak involves the Bundibugyo strain, a rare species of the virus. This particular strain kills about one-third of those infected [1, 5]. Because no vaccine exists for this variant, containment relies heavily on traditional public-health measures, and patient isolation.
Dr. Tedros said the rise in suspected cases necessitates the risk upgrade to ensure a more aggressive response. The WHO continues to monitor the movement of the virus across borders to prevent a wider regional crisis.
“The risk in the wider region in Africa is "high", but it remains "low" globally.”
The upgrade to 'very high' risk signals that the outbreak has moved beyond a localized cluster into a phase where existing medical tools are insufficient. Because the Bundibugyo strain is rare and lacks a vaccine, the WHO cannot rely on the rapid immunization strategies used in previous Zaire strain outbreaks, making the containment of the virus in Ituri Province significantly more difficult.
